Construction is to begin on the 22,000-square-foot facility this month and be completed by next year, the Dallas Business Journal reported Feb. 5. The company filed for a license to build the facility Feb. 4.
The billionaire investor and “Shark Tank” TV show star announced the company in January, saying it is dedicated to producing low-cost versions of high-cost generic drugs and pledged to “provide radical transparency in how we price our drugs.”
Read the full article here.
More articles on pharmacy:
AstraZeneca’s vaccine may not effectively protect against South Africa variant, small trial shows
20 most expensive prescription drugs in 2021
Pentagon to deploy troops to help with COVID-19 vaccine administration
